Received Feb 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | UNK | — | OT |
accidentally received a dose of FLUZONE HD last 07Jan2026/ patient had already received a dose of FLUZONE HD prior, on 02Oct2025, with no reported adverse event; Initial information received on 11-Feb-2026 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 68 years old male patient who accidentally received a dose of Influenza Usp Trival A-B High Dose Subvirion Vaccine [Fluzone Hd]- last 07-jan-2026 and had already received a dose prior, on 02-oct-2025, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Jan-2026, the patient accidentally received 0.5mL of suspect Influenza Usp Trival A-B High Dose Subvirion Vaccine, Suspension for injection in pre-filled syringe (lot U8855CA, expiry date 30-Jun-2026, frequency once and strength High dose) via intramuscular route in the right deltoid for Immunisation and had already received an unknown dose prior(lot and expiry date unknown), on 02-Oct-2025 , with no reported adverse event (extra dose administered) (latency same day). It was reported "Patient did not show any adverse reactions." Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.